Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2026)

Elanco Animal Health has disclosed Capital Expenditures across 10 years of filings, most recently posting $33.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 42.11% year-over-year to $33.0 million; the TTM figure through Jun 2026 stood at $238.0 million (up 12.8% YoY), while the FY2025 annual figure was $276.0 million, up 87.76% from the prior year.
• Capital Expenditures came in at $33.0 million for Q2 2026 at Elanco Animal Health, down from $51.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $92.0 million in Q3 2025 to a low of $19.0 million in Q1 2022.
• Average Capital Expenditures over 5 years is $45.4 million, with a median of $41.5 million recorded in 2023.
• Year-over-year, Capital Expenditures plunged 46.75% in 2023 and jumped 170.83% in 2025.
• Over 5 years, Capital Expenditures stood at $77.0 million in 2022, then tumbled by 46.75% to $41.0 million in 2023, then climbed by 14.63% to $47.0 million in 2024, then jumped by 31.91% to $62.0 million in 2025, then plunged by 46.77% to $33.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $33.0 million in Q2 2026, $51.0 million in Q1 2026, and $62.0 million in Q4 2025.